162 related articles for article (PubMed ID: 31027071)
21. [Liver damage detected after a hepatectomy for liver metastasis after 12 courses of mFOLFOX6 therapy as an adjuvant chemotherapy for colorectal cancer].
Makino S; Murata K; Murakami M; Wada Y; Kato R; Nishigaki T; Owada Y; Okada K; Yanagisawa T; Okamura S; Ebisui C; Yokouchi H; Kinuta M; Nakagomi N; Tamai M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2222-4. PubMed ID: 23268030
[TBL] [Abstract][Full Text] [Related]
22. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
[TBL] [Abstract][Full Text] [Related]
23. [A case of resection of synchronous multiple liver metastases from colorectal cancer after FOLFOX chemotherapy].
Otsuka S; Inagaki M; Nishie M; Hamano R; Tokunaga N; Takahashi K; Tsunemitsu Y; Miyoshi K; Takahashi M; Oosaki T; Iwagaki H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):501-4. PubMed ID: 19295281
[TBL] [Abstract][Full Text] [Related]
24. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.
Power DG; Kemeny NE
Crit Rev Oncol Hematol; 2011 Sep; 79(3):251-64. PubMed ID: 20970353
[TBL] [Abstract][Full Text] [Related]
26. [A long-term survival case of liver and mediastinal LN metastases from colon cancer treated with intensive multimodal therapy].
Nakahara O; Beppu T; Ishiko T; Mizumoto T; Masuda T; Hosaka S; Okabe H; Takamori H; Kanemitsu K; Hirota M; Baba H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1792-4. PubMed ID: 17212109
[TBL] [Abstract][Full Text] [Related]
27. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
[TBL] [Abstract][Full Text] [Related]
28. [A case of resected rectal cancer with hepatic node and multiple liver metastases effectively treated by preoperative modified FOLFOX6 and sLV5FU2 chemotherapy].
Seshimo K; Oishi M; Toshima T; Ikeda H; Kato H; Yamamura M; Kodera M; Yamashita Y; Tanaka N; Fujita H; Shibagaki K; Taniguchi H; Matsuki T; Kobayashi K; Takita K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):477-80. PubMed ID: 22421784
[TBL] [Abstract][Full Text] [Related]
29. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
Uetake H; Yasuno M; Ishiguro M; Kameoka S; Shimada Y; Takahashi K; Watanabe T; Muro K; Baba H; Yamamoto J; Mizunuma N; Tamagawa H; Mochizuki I; Kinugasa Y; Kikuchi T; Sugihara K
Ann Surg Oncol; 2015 Mar; 22(3):908-15. PubMed ID: 25465375
[TBL] [Abstract][Full Text] [Related]
30. [A case of sigmoid colon cancer with liver and ovarian metastases effectively treated by panitumumab after acquiring resistance to prior chemotherapy regimens].
Honda K; Hata Y; Ihara E; Tomita Y; Miyata S; Sumida Y; Ihara Y; Misawa T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1533-6. PubMed ID: 21918357
[TBL] [Abstract][Full Text] [Related]
31. [Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
Kobayashi K; Ueki K; Ishizuka D; Wakakuwa R
Gan To Kagaku Ryoho; 2005 Mar; 32(3):389-91. PubMed ID: 15791824
[TBL] [Abstract][Full Text] [Related]
32. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).
Folprecht G; Gruenberger T; Bechstein W; Raab HR; Weitz J; Lordick F; Hartmann JT; Stoehlmacher-Williams J; Lang H; Trarbach T; Liersch T; Ockert D; Jaeger D; Steger U; Suedhoff T; Rentsch A; Köhne CH
Ann Oncol; 2014 May; 25(5):1018-25. PubMed ID: 24585720
[TBL] [Abstract][Full Text] [Related]
33. Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous Polyposis.
Toiyama Y; Inoue Y; Kitajima T; Okigami M; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Int Surg; 2014; 99(6):795-801. PubMed ID: 25437589
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T
Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185
[TBL] [Abstract][Full Text] [Related]
35. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
[TBL] [Abstract][Full Text] [Related]
36. [A Case of Conversion Surgery for Unresectable Colorectal Liver Metastases, Following Effective Combined Chemotherapy with Molecular Targeting Agents].
Nakashima C; Suzuki N; Tomochika S; Tanaka H; Tokumitsu Y; Kanekiyo S; Tokuhisa Y; Iida M; Sakamoto K; Takeda S; Yamamoto S; Yoshino S; Hazama S; Ueno T; Nagano H
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1272-1274. PubMed ID: 29394604
[TBL] [Abstract][Full Text] [Related]
37. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].
Yoshida R; Matsuura T; Hijikawa K; Yanagida H; Kitade H; Takada H; Kwon AH
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1575-7. PubMed ID: 23064076
[TBL] [Abstract][Full Text] [Related]
38. [A Case of Neuroendocrine Carcinoma of the Ascending Colon That Responded Completely to Chemotherapy].
Satake M; Yoshimatsu K; Ito Y; Imaizumi R; Sano M; Kodera A; Miyano Y; Koike T; Yamada Y; Okayama S; Yokomizo H; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1513-1515. PubMed ID: 30382062
[TBL] [Abstract][Full Text] [Related]
39. [A Case of Pathological Complete Response of Colon Cancer after Systemic Chemotherapy with mFOLFOX6].
Otani A; Inoue M; Otani T; Watanabe N; Hayashi T
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1750-1752. PubMed ID: 33468817
[TBL] [Abstract][Full Text] [Related]
40. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
